IFI16 and nonpapillary renal cell carcinoma: These experiments collectively demonstrate that knocking down IL6 can reverse the enhanced effects of IFI16 overexpression on ccRCC proliferation, migration, invasion, EMT, and the PI3K/AKT signaling pathway.